Financial Institutions: Banks and Trusts January 20, 2017

Rating Report

Home Capital Group Inc.

Ratings

Rating Considerations

Franchise Strength: Home Capital Group’s (HCG or the Group) market leading position in the niche non-prime uninsured single-

family mortgage lending throughout Canada is a key consideration in the ratings.

Earnings Power: HCG’s

leading market position

provides for solid revenue

generation; however,

recent initiatives have

resulted in operating costs

outpacing revenue growth,

pressuring earnings.

Risk Profile: DBRS considers

HCG’s risk profile as above

that of bank peers, given the

nature of HCG’s uninsured

non-prime portfolio. Moreover,

DBRS is cautious that any real

estate market correction could

adversely affect HCG.

Funding and Liquidity: The

majority of the Group’s funding is

broker-sourced, which is considered to

be of lesser quality than branch-based

deposits. Positively, HCG is placing

more emphasis on its direct-to-

customer Oaken Financial and Home

Bank deposits.

Capitalization: HCG

through its operating

subsidiary Home Trust

Company (HTC or the Trust

Company) enjoys a high

common equity tier 1

(CET1) ratio relative to

banking peers.

Rating Drivers

Factors with Positive Rating Implications Factors with Negative Rating Implications Meaningful increase of funding through direct

deposits, thereby reducing dependence on brokered

source deposits.

Noticeable diversification of income and

introduction of more fee-based and non-interest

income.

Inability to restore positive operating leverage due to the

failure to successfully execute upcoming initiatives aimed at

stemming leakage from existing portfolio, while not

improving broker customer service on the front end.

Significant losses in the loan portfolio due to unforeseen

weakness in the underwriting and/or risk management

process.

Material loss of market share or substantially lower

originations due to new Department of Finance mortgage

rules. NB: Operating leverage as calculated by DBRS.

Financial Information

IFRS

(IFRS data in CAD $m) 9M 2016 9M 2015Q1 2014 2015 2014 2013 2012 2011

Loans under Administration (LUA) 26,013 23,427 25,058 22,564 19,942 18,042 16,090

Total Mortgage Originations (on-balance sheet) 6,798 5,905 8,059 8,851 6,917 6,005 5,117

Net Interest Income 365 354 481 460 422 381 334

Net Non-Interest Income 73 80 104 133 75 56 35

Efficiency Ratio (%) 38.4% 31.3% 32.6% 27.4% 28.9% 28.1% 28.5%

Return on Average Common Equity (%) 16.4% 19.2% 18.7% 23.8% 23.9% 25.5% 27.1%

Gross Impaired Loans (GILs) / Gross Non-Securitized Loans (%) 0.4% 0.4% 0.3% 0.4% 0.5% 0.6% 0.5%

Liquid Assets* / Non-Securitized Assets 8.9% 5.9% 9.0% 5.8% 7.8% 5.9% 9.8%

Common Equity Tier 1 Ratio (Basel III) (%) ** 16.5% 18.1% 18.3% 18.3% 16.8% N/A N/A

** Ratios prior to 2013 are Basel II

Source: Company reports, DBRS

For the Year Ended Dec 31As of Sep 30

* Liquid assets includes unencumbered cash and cash equivalents, and available for sale securities

Issuer Debt Rating Rating Action Trend Home Trust Company Issuer Rating BBB (high) Confirmed Negative

Home Trust Company Deposits & Senior Debt BBB (high) Confirmed Negative

Home Trust Company Short-Term Instruments

R-2 (high) Confirmed Negative

Home Capital Group Inc. Senior Debt BBB Confirmed Negative

Home Capital Group Inc. Short-Term Instruments R-2 (middle) Confirmed Negative

David Laterza, CPA +1 212 806 3270

dlaterza@dbrs.com

Maria-Gabriella Khoury, CFA +1 416 597 7561

mkhoury@dbrs.com

Financial Institutions: Banks and Trusts

January 20, 2017

Rating Report | Home Capital Group Inc.

DBRS.COM 2

Issuer Description

HCG, through its primary operating subsidiary HTC, is engaged in residential mortgage lending, mainly to non-prime borrowers,

commercial mortgage lending, credit card lending and a modest amount of other consumer lending. HCG balance sheet assets at the end

of Q3 2016 were almost $20.3 billion, with total assets under administration (AUA) of $28.3 billion.

Rating Rationale

On December 19, 2016, DBRS Limited (DBRS) confirmed Home Trust Company’s (HTC or the Company) Issuer Rating and Deposits

and Senior Debt rating at BBB (high) and Short-Term Instruments rating at R-2 (high). HTC is the primary operating subsidiary of Home

Capital Group Inc. (HCG or the Group). DBRS has also confirmed the Group’s Senior Debt rating at BBB and Short-Term Instruments

rating at R-2 (middle). Concurrently, the trend on all ratings has been revised to Negative from Stable. Under DBRS’s Global Methodology

for Rating Banks and Banking Organisations, HTC has an intrinsic assessment of BBB (high) and a support assessment of SA3. The SA3

rating, which reflects the expectation of no timely external support, results in the final rating being equivalent to the intrinsic assessment.

The rating action follows a detailed review of the Group’s operating results, financial fundamentals and future prospects.

The Negative trend reflects DBRS’s view that the Department of Finance Canada’s new mortgage rules, which took effect October 2016,

will likely have a negative impact on the Group’s origination volumes as well as loans under administration (LUA) and, as a result, be a

headwind to profitability. Moreover, these rules come at a time when the Group is already challenged by some loss of market share in its

core broker channels because of (1) customer service issues with its mortgage broker customers and (2) customer-retention issues on the

back end of its portfolio. These challenges, combined with actions taken to enhance its risk-management capabilities, have caused

operating efficiency to deteriorate, creating a headwind to earnings growth. DBRS expects HCG to announce in early 2017 details on

initiatives designed to restore the Company to positive operating leverage, but expects the execution of these initiatives to take time.

In confirming the ratings, DBRS acknowledges HCG’s leading position in the niche non-prime single-family mortgage market, which

enjoys higher margins and historically strong profitability. In addition, the Company’s strong regulatory capital ratios and consistent ability

to generate internal capital are considered in the ratings. These positive attributes are offset by geographic concentration in the loan

portfolio and past exposure to fraudulent mortgage applications, increased operating costs as a result of the enhancement of risk processes

and dependence on brokers for both mortgage and deposit generation.

HCG has $26.0 billion in LUA, $17.9 billion of which is on balance sheet, excluding loans held for sale. The Group has a significant focus

on the niche Canadian Alt-A market, where it is the largest market player. As at Q3 2016, the Group had $11.4 billion of non-prime

uninsured residential mortgages in its portfolio. HCG specializes in underwriting such mortgages, where the difficulty lies in income

verification (generally because of the borrower being self-employed or a new immigrant) rather than in the borrower’s creditworthiness

or the value of the underlying asset. At the same time, the Group also originates insured mortgages that are generally securitized after

origination through the Canada Mortgage and Housing Corporation’s (CMHC) National Housing Act Mortgage-Backed Securities (NHA-

MBS) and Canada Mortgage Bond (CMB) programs. As at Q3 2016, on-balance sheet-insured residential mortgages, including residential

commercial, stood at $3.9 billion. In addition, HCG has around $1.9 billion in commercial mortgages and $0.7 billion in credit card and

small consumer loans.

Revenue generation remains solid despite the challenges noted above, with net interest income increasing by 3% year over year (YOY) to

$365 million in 9M 2016 from $354 million in 9M 2015. However, recent risk-improvement initiatives have resulted in non-interest

expense outpacing revenue growth and negatively affecting HCG’s relatively good operating efficiency metrics. Indeed, non-interest

expense increased by 23% YOY to $168 million in 9M 2016 from $136 million in 9M 2015, mainly because of increased head count,

ongoing investment in information technology security platforms and initiatives to strengthen risk management and compliance. As a

result, net income fell by 9% during the same period to $197 million in 9M 2016. Although HCG is focusing on improving its operating

leverage through higher revenue growth and reducing costs, DBRS expects the latter will be difficult to achieve in the short term, as some

of the risk-management initiatives the Group has invested in are labour-intensive.

Despite the suspension of approximately 45 brokers who have been identified as being associated with falsified mortgage applications in

2014, HCG has been successfully managing its uninsured Alt-A portfolio, which makes up 44% of LUA, as evidenced by the Group’s

low loan impairments and losses. However, DBRS is being cautious, as HCG is more susceptible to a real estate market correction than

peers because of the nature of its portfolio. Furthermore, a 24% increase in its commercial mortgage loans during the year, which reached

$1.9 billion in Q3 2016, in DBRS’s view exposes HCG to wholesale risk at a time when the Group is concentrating on anchoring its

enhanced retail risk-management processes.

The Group is highly dependent on brokers for both its mortgage and deposit origination. To improve funding, HCG is growing its direct

deposit channel through its Oaken Financial offering as well as through its subsidiary, Home Bank (formerly CFF Bank, which it acquired

in October 2015). With a limited buffer of unencumbered assets, DBRS views further growth in directly sourced deposits positively, as it

Financial Institutions: Banks and Trusts

January 20, 2017

Rating Report | Home Capital Group Inc.

DBRS.COM 3

would further enhance liquidity and funding. In addition, the Group initiated an asset-backed commercial paper (ABCP) funding program

in April 2016 for its uninsured near-prime residential mortgages. While this program adds diversity, the short-term nature of such programs

does introduce refinancing risk; however, DBRS expects the program to remain a very modest component of the Group’s overall funding.

HTC is regulated by the Office of the Superintendent of Financial Institutions and thus is subject to Basel III capitalization requirements.

As at Q3 2016, HTC reported a CET1 ratio of 16.54%, one of the highest ratios among peers, giving HTC a buffer to contain potential

loan losses. In addition, DBRS ran its Canadian residential mortgage-backed securities model (including home equity line of credit) on

the uninsured residential mortgage portfolio using static loan-level data to gain an understanding of how the portfolio might act in the

event of material market declines. The analysis showed that the expected loss in the mortgage portfolio during a significant real estate

market correction is manageable. However, given the share buybacks that HCG undertook in 2016, DBRS also notes that the Group has

to be cognizant of maintaining capital ratios at their currently high levels relative to regulatory minimums to maintain a sufficient cushion

for the underwriting risk HCG undertakes relative to peers.

Franchise Strength

HCG is predominantly a specialized residential mortgage lender focused on non-prime customers. In addition, the Group is engaged in

commercial mortgage lending, credit card lending that is virtually all real estate secured, and a modest amount of other consumer lending.

Mortgage loans are primarily sourced from brokers and are mostly funded by brokered deposits.

The Group, which is a publicly listed company on the Toronto Stock Exchange, operates through its principal subsidiary HTC. HTC is

federally regulated by the Office of the Superintendent of Financial Institutions (OSFI) and represents virtually all of HCG’s business.

The other operating subsidiary, Payment Services Interactive Gateway Inc., offers electronic card-based services to merchants, but is very

small and makes only a small contribution to earnings.

In Q3 2016, LUA reached $26.0 billion, an increase of 4% over YE2015 and 11% from Q3 2015. On-balance sheet gross loans declined

by 1% from year-end 2015 to $17.9 billion in Q3 2016. This portfolio includes HCG’s securitized loans, which are predominantly insured

mortgages. The Group’s main insured single-family product is called Accelerator.

HCG is the leader in the non-prime uninsured single-family residential mortgage market. Its clients include self-employed persons, people

with previous credit problems, new immigrants with no Canadian credit history and newly employed individuals. This segment of the

market, referred to as Alt-A, is where verification and documentation is cumbersome rather than a reflection of the borrower’s

creditworthiness or value of the underlying asset. DBRS notes that all loan applications are still subject to OSFI’s B-20 guidelines.

Uninsured non-prime products include the traditional single-family Alt-A residential mortgages, which made up 72% of on-balance sheet,

unsecuritized loans and ACE Plus single-family mortgages, which are near-prime residential mortgages and comprise 3% of the portfolio.

On-balance sheet securitized mortgages totalled $2.5 billion in Q3 2016 and comprise primarily insured single-family and multi-unit

residential mortgages that are sold into CMHC’s NHA-MBS and Canada Mortgage Bond CMB programs.

Financial Institutions: Banks and Trusts

January 20, 2017

Rating Report | Home Capital Group Inc.

DBRS.COM 4

The majority of mortgages are broker-originated and are generally diversified across the country, although loans are concentrated within

Ontario, which comprises 84% of the portfolio, with an additional 6% in British Columbia and 4% in Alberta. HCG focuses its

underwriting on residences in urban and suburban areas.

There is some uncertainty as to how the new Department of Finance mortgage rules will affect HCG’s originations, since they only took

effect late in 2016. Management believes the rules will certainly have an effect on the Accelerator product (insured single-family mortgage

originations) which HCG generates only for the purposes of securitization. Specifically, the rules will potentially limit HCG’s ability to

profitably originate and fund these mortgages as they are traditionally a low-margin product. More clarity is expected as the Group

announces results for Q4 2016 and Q1 2017, but management expects up to a 60% decline in its Accelerator originations. As such, the

Group will review its mid-term (three- to five-year targets) in Q4 2016.

Commercial lending has increased over the last year, with non-residential commercial mortgages rising 27% YOY to $1.9 billion in Q3

2016. These mortgages are sourced through brokers or partners. The Group has stated that it will strategically continue to grow this

segment if market conditions remain favourable, since the portfolio provides HCG with high yields and asset diversification.

HCG’s other ancillary businesses include a $374 million Visa portfolio as at September 30, 2016. This portfolio is predominantly a product

called Equityline Visa, which is a home equity line of credit (HELOC) that is secured with residential mortgages as collateral. In addition,

the Group has approximately $361 million in other personal loans, largely secured by home-related assets. HCG is also expanding into

other lending products, such as unsecured credit cards, where it has limited experience. Given its limited scale and management’s

announced plans for slow expansion, DBRS does not anticipate that this growth in consumer lending would add significantly to the Group’s

risk profile. Together, these products currently contribute around 4% to HCG’s loan portfolio.

HTC offers deposits via brokers and financial planners, and through its direct-to-consumer deposit brand, Oaken Financial. HTC also

conducts business through its wholly owned subsidiary, Home Bank (formerly CFF Bank), which HTC acquired in October 2015. HTC

has six “trust branch” offices in Ontario, Alberta, British Columbia, Nova Scotia, Québec and Manitoba, and two Oaken Financial stores,

one in Toronto and the other in Calgary.

HCG’s executive team has been growing over the last couple of years, with the new leadership settling into their roles. This mitigates to

some degree DBRS’s concerns about the depth of the management succession pool.

Earnings Power

As the market leader in the non-prime mortgage lending space, HCG enjoys better margins and access to securitization pools versus its

peers, which lends to higher profitability. Nevertheless, operating efficiency has suffered as the Group increased spending on risk

management and mortgage retention programmes.

Net interest income (NII), increased by 3% YOY to $365 million in 9M 2016, despite a 1% retraction in the gross loan portfolio from 9M

2015. In response to the low interest rate environment, which has compressed margins, HCG has altered some of its product mix,

introducing new securitization pools and increasing its commercial lending. Net interest margin (NIM) was up modestly to 2.44% in 9M

2016 from 2.39% in the comparable period a year ago.

Non-interest income declined by 8% YOY to $73 million for 9M 2016, due to a 14% decrease in fees and other income, which came about

due to changes in the portfolio mix and fee structure. Meanwhile, securitization income increased by 21% as HCG sold the residual interest

in both single-family and multi-unit mortgage securitizations. DBRS notes that non-interest income makes up around 10% of total revenues

and would view favourably a greater contribution to revenues of non-interest income.

In the aftermath of the suspension of the 45 brokers in 2014 and 2015, HCG has upgraded processes, changed business relationships,

increased regulatory compliance activities and introduced additional risk management procedures. These changes resulted in increased

costs and has strained the ability to grow assets and net revenue. As such, HCG has invested in improving broker service and borrower

retention levels through two initiatives: Spire, a broker partnership and incentive program rolled out in 2016, and Loft, a broker portal

technology that was created to enhance the broker experience, as well as improve service levels by increasing transparency, which will be

rolled out in 2017. As a result, the efficiency ratio deteriorated to 38.4% in 9M 2016 from 31.3% in 9M 2015.

Financial Institutions: Banks and Trusts

January 20, 2017

Rating Report | Home Capital Group Inc.

DBRS.COM 5

The Group’s main focus now is on improving operating leverage by driving revenue growth and reducing expenses. On the revenue side,

the strategic focus is to improve the retention of customers at renewal and compelling business lines to increase revenues, while on the

expense side HCG is will look to optimize its cost structure. DBRS believes the latter will be difficult to achieve in the short term as the

Group has had to invest in risk management initiatives some of which are labour-intensive.

According to management, the probable decrease in insured mortgage originations due to new mortgage rules are expected to have an

impact on net income before tax of approximately $6.5 million, as the Accelerator programme has traditionally been a low-margin product.

However, in DBRS’s opinion, the Department of Finance Canada’s new mortgage rules, which took effect October 2016, will likely have

a negative impact on the Group’s origination volumes as well as LUA and, as a result, could prove to be a greater headwind to profitability.

Furthermore, Home Bank will continue to incur operating losses until it is fully integrated.

Provisions for credit losses decreased by 27% YOY to $5.5 million in 9M 2016, while the current collective allowance exceeds the

cumulative net write-offs experienced over the last 36 months. Consequently, provisions to income before provisions and taxes (IBPT)

decreased from 2.5% in 9M15 to 2.0% in 9M 2016. In DBRS’s view, however, given the nature of the uninsured residential portfolio and

with an increase in commercial lending HCG’s write-offs may increase, especially if there is a real estate market correction, and thus

provisioning levels may rise.

Return on average common equity decreased to 16.4% in 9M 2016, from 19.2% in 9M 2016, as net income fell by 9% YOY to $197

million in 9M 2016 due to negative operating leverage.

Risk Profile

With the majority of its portfolio in non-prime single family mortgages, DBRS considers HCG’s risk profile as above that of its bank

peers. While DBRS acknowledges the Group’s traditionally solid underwriting and servicing of the uninsured Alt-A portfolio, as evidenced

by the low level of impairments and loan losses, in DBRS’s view HCG is more susceptible to real estate market corrections than other

lenders.

When underwriting uninsured mortgage loans, which is an important component of HCG’s business, the Group focuses more on property

appraisals and ensuring lower LTV ratios than is typical for prime mortgages in order to reduce credit risk. The current weighted average

LTV of uninsured residential mortgages was 63.6% as of Q3 2016 compared 66.0% for YE2015.

With the exception of a small portion of consumer loans, almost all of HCG’s lending is secured by real estate, with 20% of on-balance

sheet lending insured, while the uninsured portion comprises primarily Alt-A single-family mortgages. Credit performance on the single-

family mortgage portfolio has historically experienced low levels of impairment. Indeed, for 9M 2016 gross impaired loans on single-

family mortgages averaged 0.35% of gross loans, while write-offs of unsecuritized loans were negligible at 0.03% in 9M 2016. Despite

HCG’s ability to successfully manage or sell its impaired loans, DBRS considers such low levels of loan losses as not likely to be

sustainable should real estate prices begin to depreciate.

Financial Institutions: Banks and Trusts

January 20, 2017

Rating Report | Home Capital Group Inc.

DBRS.COM 6

Meanwhile, given their secured nature, the Group’s ancillary credit card loans businesses’ impaired loans have been low, totalling 0.56%

in Q3 2016, while other consumer retail loans were 0.08%.

Events in 2014–2015 led HCG to suspend relationships with a group of approximately 45 brokers identified as being associated with

falsified mortgage applications. HCG has completed the review of the $1.14 billion portfolio of loans outstanding as of Q3 2016 generated

by these suspended brokers. There have been no unusual credit issues on these mortgages.

Non-residential commercial mortgages, which includes store and apartments, office buildings, residential and non-residential construction,

hotels and industrial properties increased by 24% from year-end 2015 to $1.9 billion at the end of September 2016. While commercial

lending adds a degree of diversification, DBRS is cautious that HCG is growing this portfolio and increasing its exposure to commercial

real estate, especially given concerns that commercial property markets may tend to have higher loss content, especially at times of a

potentially slowing economy.

The Group is heavily reliant on external brokers for the origination of both mortgages and deposits, which causes some concentration risk,

especially when dealing with some of the major brokerage firms. In addition, HCG faces geographic risk as 84% of single-family

residential mortgages are Ontario-based, with another 6% in British Columbia, 4% in Alberta and the rest distributed among other

provinces.

HCG has been improving its risk management processes and procedures since the suspension of the brokers in 2014–2015. As the new

systems have now been institutionalized into the Group’s practices, HCG is now concentrating on making these procedures more efficient

and creating a more transparent application process for brokers and, in turn, borrowers.

The Group is subject to investment and interest rate risk that is used to hedge its exposure. In DBRS’s view, the integration of Home Bank,

combined with the implementation of Spire and Loft, could increase operational risks.

Funding and Liquidity

DBRS considers HCG’s reliance on confidence-sensitive broker deposits as a weakness. As such, DBRS views the strategy to transition

the deposit base to more direct-to-consumer-sourced deposits favourably, but recognizes that this will take time and has execution risks.

As of September 30, 2016, approximately 83% of HCG’s $15.7 billion deposits were sourced through brokers. Although this is an

improvement from 86% at YE2015, the Group continues to introduce products to directly acquire deposits through its Oaken Financial

and Home Bank offerings and, to a smaller extent, through wholesale deposit notes. HCG’s uninsured mortgages have a weighted-average

life (WAL) of around two years, compared to the usual five-year WAL for prime mortgages (amortization periods are the same, typically

25 years), which facilitates HCG’s ability to match-fund its term assets with liabilities of a similar tenor, especially given its reliance on

broker deposits and wholesale funding.

The Group funds insured residential and multi-residential mortgages through CMHC’s sponsored programs, CMB and NHA MBS, providing

some diversity to funding and a consistently accessible channel of liquidity. In addition, HCG established an ABCP funding program for its

ACE Plus (near prime) residential mortgages in April 2016. Securitizations, including ABCP, formed 15% of total funding as of Q3 2016.

Financial Institutions: Banks and Trusts

January 20, 2017

Rating Report | Home Capital Group Inc.

DBRS.COM 7

In May 2016, HTC retired three Subordinated Debt notes with HCG totalling $156 million. This corresponded to the majority of HCG’s

$150 million Senior Debt.

HCG maintains a pool of unencumbered liquid assets, which are defined as cash, short-term bank deposits, treasury bills, banker’s

acceptances, government bonds, insured mortgage-backed securities and Canadian bank bonds. At the end of Q3 2016, HCG reported its

unencumbered liquidity pool was $1.9 billion, or 9.2% of total assets, versus $1.5 billion or 7.3% of total assets in Q3 2015. These liquid

assets mostly comprise cash and cash equivalents, which stood at $1.1 billion at the end of Q3 2016, in addition to about $0.8 billion of

securities. HTC is not required to disclose its Basel III Liquidity Coverage Ratio (LCR); however, the Trust Company does calculate the

LCR, which it shares with OSFI as part of the supervisory review process. HTC has disclosed that it is adhering fully with OSFI’s liquidity

guidelines.

Capitalization

From DBRS’s perspective, the Trust Company benefits from capitalization levels that are the highest among its peers. This leaves HTC

with a sufficient cushion to withstand any major stresses. Internal capital generation is strong as the dividend payout has historically been

low; in addition, the Group is participating in share buyback programmes.

While the operating subsidiary HTC is regulated by OSFI, HCG is not directly regulated. HTC maintains very strong regulatory ratios,

with a Basel III CET1 capital ratio of 16.5% as of the end of Q3 2016, well above the regulatory minimum of 7%. DBRS estimates this

leaves the Group with a capital cushion of approximately $803 million (based on total risk-weighted assets) to absorb potential loan losses.

HTC follows the standardized Basel III approach on an all-in basis, and at the current moment there are no projects underway to implement

the advanced ratings-based approach.

Financial Institutions: Banks and Trusts

January 20, 2017

Rating Report | Home Capital Group Inc.

DBRS.COM 8

While still above bank peers, HTC’s CET1 has fallen from 18.3% at YE2015 due to higher risk-weighted assets as a result of growth in

non-residential commercial loans and a decrease in retained earnings due to share repurchases, as well as a higher dividend payout. HCG

completed a Substantial Issuer Bid (SIB) for 3.9 million common shares in April 2016, for proceeds of approximately $150 million, in

addition to participating in Normal Course Issuer Bids (NCIB) totalling $44 million for 9M 2016. HCG renewed the NCIB through to

September 2017, providing HCG with the option to repurchase up to 5% of outstanding shares. The purchase cost of shares acquired

through the repurchase of shares is allocated between capital stock and retained earnings. The Company expects to continue to participate

in these share buyback programmes going forward.

HCG’s ability to internally generate capital on a consistent basis has been strong, driven by high ROE and a historically low dividend

payout, which reached a high of 24.6% in 9M 2016, thus providing HCG with a considerable amount of capital flexibility. Management

has indicated that it will be revising its dividend payout targets in Q4 2016.

DBRS ran its Canadian residential mortgage-backed securities model (including HELOC) on the uninsured residential mortgage portfolio

using static loan-level data to gain an understanding of how the portfolio might act in the event of material market declines. The analysis

suggests HTC would remain above regulatory minimums and weather such an unfavourable scenario. Nevertheless, DBRS notes, given

the share buybacks HCG undertook in 2016, the Group should make an effort to maintain capital ratios at their current high levels above

regulatory minimums in order to keep such a buffer, due to the underwriting risk HCG undertakes relative to peers.

Financial Institutions: Banks and Trusts

January 20, 2017

Rating Report | Home Capital Group Inc.

DBRS.COM 9

Home Capital Group Inc.Balance Sheet IFRS IFRS IFRS IFRS IFRS IFRS IFRS

($ millions) 9M 2016 9M 2015 2015 2014 2013 2012 2011

Assets:

Cash and Cash Equivalents 1,059 612 1,150 361 733 302 534

Restricted Cash and Investments 231 494 196 421 648 725 473

Investments 523 413 453 583 424 414 392

Mortgages - Non-Securitized 15,342 15,238 15,423 14,283 12,640 10,402 7,817

Mortgages - Securitization 2,549 2,901 2,674 3,946 5,210 6,706 8,243

Loans Held for Sale 74 162 135 102 138 22 0

Other Assets 538 494 496 387 282 228 237

Total Assets 20,317 20,314 20,527 20,083 20,076 18,800 17,696

Liabilities & Equity:

Deposits 15,694 14,950 15,666 13,940 12,766 10,137 7,922

Securitization Liabilities 2,680 3,318 2,781 4,303 5,773 7,336 8,649

Debt 0 154 151 152 153 151 153

Other Liabilities 363 323 308 239 206 209 197

Total Liabilities 18,738 18,745 18,906 18,634 18,898 17,832 16,922

Common Equity 1,579 1,569 1,621 1,449 1,178 968 775

Total Equity 1,579 1,569 1,621 1,449 1,178 968 775

Total Liabilities and Equity 20,317 20,314 20,527 20,083 20,076 18,800 17,696

Source: Company reports, DBRS

Home Capital Group Inc.Income Statement IFRS IFRS IFRS IFRS IFRS IFRS IFRS

($ millions) 9M 2016 9M 2015 2015 2014 2013 2012 2011

Interest Income - Core Lending 578 573 770 718 629 526 401

Interest Income - Securitization 62 81 104 166 226 288 330

Interest Income - Other 16 14 19 25 19 18 24

Total Interest Income 655 668 892 910 874 832 755

Interest Expense - Deposits 237 241 319 311 268 230 192

Interest Expense - Securitization Liabilities 52 68 86 132 178 213 225

Interest Expense - Other 2 5 6 6 7 7 4

Total Interest Expense 291 313 411 450 453 450 421

Net Interest Income 365 354 481 460 422 381 334

Fees and Other Income 54 63 83 71 61 44 38

Securitization Income 25 20 26 27 13 8 0

Net (Loss) Gain on Investments (6) (4) (7) 3 1 4 (3)

Other 0 0 0 33 0 0 0

Operating Revenue 437 434 583 593 497 437 369

Salaries & Benefits 78 63 89 81 71 59 53

Other 90 73 102 81 73 64 52

Operating Expenses 168 136 191 162 144 123 105

Non-Operating Income/Expense 1 0 2 0 0 0 0

Income Before Provisions and Taxes (IBPT) 269 298 394 431 353 315 264

Provisions for Loan Losses 5 8 9 13 16 15 8

Income Before Taxes 264 290 385 418 337 300 256

Taxes 67 73 98 104 81 78 66

Net Income to Shareholders 197 217 287 313 257 222 190

Source: Company reports, DBRS

Financial Institutions: Banks and Trusts

January 20, 2017

Rating Report | Home Capital Group Inc.

DBRS.COM

1

0

Profitability Ratios IFRS IFRSIFRS IFRS IFRS IFRS IFRS IFRS

9M 2016 9M 2015Q1 2014 2015 2014 2013 2012 2011

Return on Average Common Equity (%) 16.39% 19.18% 18.72% 23.85% 23.91% 25.47% 27.09%

Return on Average Assets(%) 1.28% 1.43% 1.41% 1.56% 1.32% 1.22% 1.14%

Net Interest Margin (%) 2.44% 2.39% 2.42% 2.33% 2.20% 2.12% 2.04%

Non-Interest Income / Total Revenue (%) 10.00% 10.64% 10.42% 12.79% 7.90% 6.30% 4.41%

Efficiency Ratio (%) (Op exp / Op rev) 38.39% 31.34% 32.60% 27.37% 28.92% 28.06% 28.47%

IBPT Margin (%) 37.00% 39.87% 39.59% 41.29% 37.21% 35.44% 33.38%

IBPT / Risk-Weighted Assets (%) 4.38% 5.30% 5.20% 6.29% 5.89% 6.27% 6.34%

Provisions / IBPT (%) 2.04% 2.5% 2.3% 3.0% 4.5% 4.7% 2.8%

Effective Tax Rate (%) 25.49% 25.28% 25.43% 24.99% 23.97% 25.99% 25.84%

Risk Profile Ratios IFRS IFRSIFRS IFRS IFRS IFRS IFRS IFRS

9M 2016 9M 2015Q1 2014 2015 2014 2013 2012 2011

Loan Loss Provision / Average Net Loans (%) 0.04% 0.06% 0.05% 0.07% 0.09% 0.09% 0.05%

Net Write-offs / Average Net Loans (%) 0.04% 0.03% 0.04% 0.06% 0.09% 0.07% 0.07%

Gross Impaired Loans (GILs) / Gross Loans (%) 0.32% 0.31% 0.30% 0.31% 0.36% 0.34% 0.26%

GILs / Common Equity + Reserves (%) 3.59% 3.55% 3.22% 3.85% 5.35% 5.89% 5.19%

GILs/IBPT (%) 16.18% 14.36% 13.58% 13.29% 18.36% 18.76% 15.85%

GILs / Gross Non-Securitized Loans (%) 0.38% 0.37% 0.35% 0.40% 0.51% 0.57% 0.53%

GILs (residential)/Gross Residential Mortgages 0.34% 0.32% 0.31% 0.32% 0.34% 0.35% 0.25%

Net Impaired Loans / Total Net Loans * (%) 0.31% 0.30% 0.28% 0.30% 0.35% 0.33% 0.25%

Loan Loss Allowance / Total Gross Loans (%) 0.22% 0.22% 0.22% 0.20% 0.19% 0.20% 0.19%

Loan Loss Allowances / GILs (%) 69.27% 69.41% 74.05% 64.35% 52.37% 56.99% 74.86%

Loan Loss Allowances / Risk-Weighted Assets (%) 0.48% 0.51% 0.50% 0.51% 0.52% 0.61% 0.69%

* Includes insured impaired loans

Funding & Liquidity Ratios IFRS IFRSIFRS IFRS IFRS IFRS IFRS IFRS

9M 2016 9M 2015Q1 2014 2015 2014 2013 2012 2011

Core Lending / Total deposits 98.0% 102.2% 98.7% 102.7% 99.3% 102.9% 99.0%

Debt/Common Equity 0.0% 9.4% 9.0% 10.4% 12.8% 15.5% 19.6%

EBIT/Debt Interest Expense 119 65 61 66 52 45 60

Liquid Assets* / Non-Securitized Assets 8.9% 5.9% 9.0% 5.8% 7.8% 5.9% 9.8%

Liquid Assets* / Total Assets 7.8% 5.0% 7.8% 4.7% 5.8% 3.8% 5.2%

* Liquid assets includes unencumbered cash, cash equivalents and available for sale securities

Capitalisation Ratios IFRS IFRSIFRS IFRS IFRS IFRS IFRS IFRS

9M 2016 9M 2015Q1 2014 2015 2014 2013 2012 2011

Common Equity Tier 1 Ratio (Basel III) (%) * 16.5% 18.1% 18.3% 18.3% 16.8% N/A N/A

Tier 1 Ratio (Basel III) (%) * 16.5% 18.1% 18.3% 18.3% 16.8% 17.0% 17.3%

Total Common Equity / Total Assets (%) 8.1% 8.1% 8.2% 7.3% 6.0% 5.2% 4.4%

Total Risk Weighted Assets / Total Assets (%) 41.4% 38.4% 38.9% 35.8% 32.4% 29.2% 25.7%

Payout Ratio 24.6% 22.0% 22.0% 17.0% 14.9% 15.0% 14.2%

* Ratios prior to 2013 are Basel II

Source: Company reports, DBRS

Financial Institutions: Banks and Trusts

January 20, 2017

Rating Report | Home Capital Group Inc.

DBRS.COM

1

1 Rating Methodology and Approach

The applicable methodologies are Global Methodology for Rating Banks and Banking Organizations (July 2016), Rating Canadian

Residential Mortgages, Home Equity Lines of Credit and Reverse Mortgages (November 2016) and DBRS Criteria: Support

Assessments for Banks and Banking Organisations (March 2016), which can be found on the DBRS website under Methodologies.

Ratings

Rating History

Previous Action(s)

DBRS Confirms Home Trust Company’s Long Term Rating of BBB (high) and Short-Term Rating R-2 (high), Stable Trends,

December 21, 2015.

DBRS Confirms Ratings of Home Trust Company at BBB (high) and R-2 (high), December 17, 2014.

Related Research

DBRS: Home Capital Group Stable Q3 2016 Profitability; New Mortgage Rules May Impact Few Segments, November 8, 2016.

DBRS: Home Capital Reports Strong Earnings; Still Few Signs of Credit Troubles in The Mortgage Portfolio, February 16, 2016.

Previous Report

Home Capital Group Inc., Rating Report, January 11, 2016.

Issuer Debt Rating Rating Action Trend Home Trust Company Issuer Rating BBB (high) Confirmed Negative

Home Trust Company Deposits & Senior Debt BBB (high) Confirmed Negative

Home Trust Company Short-Term Instruments

R-2 (high) Confirmed Negative

Home Capital Group Inc. Senior Debt BBB Confirmed Negative

Home Capital Group Inc. Short-Term Instruments R-2 (middle) Confirmed Negative

Issuer Debt Current 2016 2015 2014

Home Trust Company Issuer Rating BBB (high) BBB (high) BBB (high) BBB (high)

Home Trust Company Deposits & Senior Debt BBB (high) BBB (high) BBB (high) BBB (high)

Home Trust Company Short-Term Instruments

R-2 (high) R-2 (high) R-2 (high) R-2 (high)

Home Capital Group Inc. Senior Debt BBB BBB BBB BBB

Home Capital Group Inc. Short-Term Instruments R-2 (middle) R-2 (middle) R-2 (middle) R-2 (middle)

Financial Institutions: Banks and Trusts

January 20, 2017

Rating Report | Home Capital Group Inc.

DBRS.COM

1

2

Notes:

All figures are in Canadian dollars unless otherwise noted.

For the definition of Issuer Rating, please refer to Rating Definitions under Rating Policy on www.dbrs.com.

Generally, Issuer Ratings apply to all senior unsecured obligations of an applicable issuer, except when an issuer has a significant or unique level of secured debt.

The DBRS group of companies consists of DBRS, Inc. (Delaware, U.S.)(NRSRO, DRO affiliate); DBRS Limited (Ontario, Canada)(DRO, NRSRO affiliate); DBRS Ratings Limited (England

and Wales)(CRA, DRO affiliate); and DBRS Ratings México, Institución Calificadora de Valores S.A. de C.V. (Mexico)(CRA, NRSRO affiliate, DRO affiliate). Please note that DBRS

Ratings Limited is not an NRSRO and ratings assigned by it are non-NRSRO ratings. For more information on regulatory registrations, recognitions and approvals, please see:

http://www.dbrs.com/research/225752/highlights.pdf.

© 2017, DBRS. All rights reserved. The information upon which DBRS ratings and reports are based is obtained by DBRS from sources DBRS believes to be reliable. DBRS does not

audit the information it receives in connection with the rating process, and it does not and cannot independently verify that information in every instance. The extent of any factual

investigation or independent verification depends on facts and circumstances. DBRS ratings, reports and any other information provided by DBRS are provided “as is” and without

representation or warranty of any kind. DBRS hereby disclaims any representation or warranty, express or implied, as to the accuracy, timeliness, completeness, merchantability, fitness for any particular purpose or non-infringement of any of such information. In no event shall DBRS or its directors, officers, employees, independent contractors, agents and

representatives (collectively, DBRS Representatives) be liable (1) for any inaccuracy, delay, loss of data, interruption in service, error or omission or for any damages resulting

therefrom, or (2) for any direct, indirect, incidental, special, compensatory or consequential damages arising from any use of ratings and rating reports or arising from any error

(negligent or otherwise) or other circumstance or contingency within or outside the control of DBRS or any DBRS Representative, in connection with or related to obtaining,

collecting, compiling, analyzing, interpreting, communicating, publishing or delivering any such information. Ratings and other opinions issued by DBRS are, and must be construed solely as, statements of opinion and not statements of fact as to credit worthiness or recommendations to purchase, sell or hold any securities. A report providing a DBRS rating is

neither a prospectus nor a substitute for the information assembled, verified and presented to investors by the issuer and its agents in connection with the sale of the securities.

DBRS receives compensation for its rating activities from issuers, insurers, guarantors and/or underwriters of debt securities for assigning ratings and from subscribers to its

website. DBRS is not responsible for the content or operation of third party websites accessed through hypertext or other computer links and DBRS shall have no liability to any person or entity for the use of such third party websites. This publication may not be reproduced, retransmitted or distributed in any form without the prior written consent of

DBRS. ALL DBRS RATINGS ARE SUBJECT TO DISCLAIMERS AND CERTAIN LIMITATIONS. PLEASE READ THESE DISCLAIMERS AND LIMITATIONS AT

http://www.dbrs.com/about/disclaimer. ADDITIONAL INFORMATION REGARDING DBRS RATINGS, INCLUDING DEFINITIONS, POLICIES AND METHODOLOGIES, ARE

AVAILABLE ON http://www.dbrs.com/.